Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Tani Y, et al. Among authors: kaneko y. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. Front Immunol. 2023. PMID: 37662950 Free PMC article.
Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021.
Sanada T, Honda T, Yasui F, Yamaji K, Munakata T, Yamamoto N, Kurano M, Matsumoto Y, Kohno R, Toyama S, Kishi Y, Horibe T, Kaneko Y, Kakegawa M, Fukui K, Kawamura T, Daming W, Qian C, Xia F, He F, Yamasaki S, Nishida A, Harada T, Higa M, Tokunaga Y, Takagi A, Itokawa M, Kodama T, Kohara M. Sanada T, et al. Among authors: kaneko y. J Epidemiol. 2022 Feb 5;32(2):105-111. doi: 10.2188/jea.JE20210324. Epub 2021 Dec 17. J Epidemiol. 2022. PMID: 34776499 Free PMC article.
Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.
Yamatsugu K, Katoh H, Yamashita T, Takahashi K, Aki S, Tatsumi T, Kaneko Y, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Kanai M, Sugiyama A. Yamatsugu K, et al. Among authors: kaneko y. Protein Expr Purif. 2022 Apr;192:106043. doi: 10.1016/j.pep.2021.106043. Epub 2021 Dec 30. Protein Expr Purif. 2022. PMID: 34973460 Free article.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A, Takita M, Ito N, Kawashima M, Sugiura S, Shibuya K, Iwami S, Kim K, Iwanami S, Kodama T, Tsubokura M. Yoshida M, et al. Among authors: kaneko y. Vaccines (Basel). 2022 Mar 26;10(4):515. doi: 10.3390/vaccines10040515. Vaccines (Basel). 2022. PMID: 35455264 Free PMC article.
The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan.
Kaneko Y, Sugiyama A, Tanaka T, Fukui K, Taguchi A, Tatsuno K, Nakayama A, Koga K, Kishi Y, Daming W, Qian C, Xia F, He F, Zheng L, Yu Y, Wada Y, Wada Y, Kodama T, Kawamura T. Kaneko Y, et al. Health Sci Rep. 2022 Apr 13;5(3):e572. doi: 10.1002/hsr2.572. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35509410 Free PMC article.
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
Kobashi Y, Shimazu Y, Kawamura T, Nishikawa Y, Omata F, Kaneko Y, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kaneko y. PLoS One. 2022 Jun 10;17(6):e0269917. doi: 10.1371/journal.pone.0269917. eCollection 2022. PLoS One. 2022. PMID: 35687563 Free PMC article.
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.
Kaneko Y, Yamatsugu K, Yamashita T, Takahashi K, Tanaka T, Aki S, Tatsumi T, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Tsukagoshi M, Chansler M, Sugiyama A, Kanai M, Katoh H. Kaneko Y, et al. Cancer Sci. 2022 Dec;113(12):4350-4362. doi: 10.1111/cas.15565. Epub 2022 Sep 19. Cancer Sci. 2022. PMID: 36121618 Free PMC article.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Kobashi Y, Kawamura T, Shimazu Y, Zhao T, Sugiyama A, Nakayama A, Kaneko Y, Nishikawa Y, Omata F, Takita M, Yamamoto C, Yoshida M, Kosaka M, Murayama A, Sugiura S, Tanaka M, Kawashima M, Uchi Y, Shindo J, Oikawa T, Shibuya K, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kaneko y. Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x. Sci Rep. 2022. PMID: 36344597 Free PMC article.
Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima.
Kobashi Y, Takebayashi Y, Yoshida M, Kawamura T, Shimazu Y, Kaneko Y, Nishikawa Y, Nakayama A, Takita M, Zhao T, Yamamoto C, Ito N, Tsubokura M. Kobashi Y, et al. Among authors: kaneko y. Vaccines (Basel). 2022 Nov 25;10(12):2007. doi: 10.3390/vaccines10122007. Vaccines (Basel). 2022. PMID: 36560417 Free PMC article.
3,374 results